BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	187,208.62 245.32M	-0.13% -246.08
ALLSHR	113,086.04 594.04M	-0.10% -112.55
KSE30	55,966.49 112.01M	-0.29% -163.91
KMI30	264,834.25 76.10M	-0.32% -854.51
KMIALLSHR	72,760.11 304.78M	-0.16% -117.98
BKTi	53,069.79 64.10M	0.36% 191.14
OGTi	38,098.48 4.87M	-0.93% -358.05

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	63,445.00	64,770.00 62,925.00	-440.00 -0.69%
BRENT CRUDE	72.87	73.08 72.04	0.88 1.22%
RICHARDS BAY COAL MONTHLY	105.75	107.20 105.75	-3.25 -2.98%
ROTTERDAM COAL MONTHLY	119.15	0.00 0.00	0.15 0.13%
USD RBD PALM OLEIN	1,135.00	1,135.00 1,135.00	0.00 0.00%
CRUDE OIL - WTI	69.34	69.54 68.58	0.79 1.15%
SUGAR #11 WORLD	15.16	15.24 14.69	0.31 2.09%